Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting.
The direct genetic modification of adenoviral capsid proteins with new ligands is an attractive means to confer targeted tropism to adenoviral vectors. Although several capsid proteins have been reported to tolerate the genetic fusion of foreign peptides and proteins, direct comparison of cell targeting efficiencies through the different capsomeres has been lacking. Likewise, direct comparison of with one or multiple ligands has not been performed due to a lack of capsid-compatible ligands available for retargeting. Here we utilize a panel of metabolically biotinylated Ad vectors to directly compare targeted transduction through the fiber, protein IX, and hexon capsomeres using a variety of biotinylated ligands including antibodies, transferrin, EGF, and cholera toxin B. These results clearly demonstrate that cell targeting with a variety of high affinity receptor-binding ligands is only effective when transduction is redirected through the fiber protein. In contrast, protein IX and hexon-mediated targeting by the same set of ligands failed to mediate robust vector targeting, perhaps due to aberrant trafficking at the cell surface or inside targeted cells. These data suggest that vector targeting by genetic incorporation of high affinity ligands will likely be most efficient through modification of the adenovirus fiber rather than the protein IX and hexon capsomeres. In contrast, single-step monomeric avidin affinity purification of Ad vectors using the metabolic biotinylation system is most effective through capsomeres like protein IX and hexon.
Campos
Samuel K
SK
The Department of Biochemistry and Cell Biology, Rice University, Houston, TX 77005, USA.
Barry
Michael A
MA
D000256:Adenoviridae / Q000235:genetics* / Q000302:isolation & purification*; D000906:Antibodies; D001360:Avidin / Q000378:metabolism; D001710:Biotin / Q000378:metabolism; D019921:Biotinylation; D036022:Capsid Proteins / Q000235:genetics / Q000378:metabolism*; D002772:Cholera Toxin / Q000378:metabolism; D004815:Epidermal Growth Factor / Q000378:metabolism; D018014:Gene Transfer Techniques; D017930:Genes, Reporter; D005822:Genetic Vectors / Q000302:isolation & purification; D006367:HeLa Cells; D006801:Humans; D008024:Ligands; D008954:Models, Biological; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D013194:Staining and Labeling; D014161:Transduction, Genetic; D014168:Transferrin / Q000378:metabolism
D000906:Antibodies; D036022:Capsid Proteins; D008024:Ligands; D011993:Recombinant Fusion Proteins; D014168:Transferrin; C018315:hexon capsid protein, Adenovirus; D001360:Avidin; D004815:Epidermal Growth Factor; D001710:Biotin; D002772:Cholera Toxin